Literature DB >> 9375321

Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits.

M R Losser1, C Bernard, J L Beaudeux, C Pison, D Payen.   

Abstract

Glucose is important for vascular and immunocompetent cell functions. We hypothesized that modifications in glucose metabolism (normal feeding, 24-h fasting, glucose loading) may influence the hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide administration (LPS; 600 micrograms/kg iv) in rabbits. Aortic (ABFV), hepatic artery (HABFV), and portal vein blood flow velocities (PVBFV) (pulsed Doppler), plasma tumor necrosis factor (TNF) and nitrites were measured. Fasting depleted hepatic glycogen content, and intraportal glucose load (2 g/kg) partially restored it. LPS induced a similar hypotension (-20%, P < 0.05) in three groups of animals. In fed animals, systemic vasoconstriction occurred with low ABFV and PVBFV (-40%, P < 0.05), together with lactacidemia and hyperglycemia. In fasted animals, ABFV and PVBFV were maintained, without metabolic acidosis or hyperglycemia. Glucose loading induced hemodynamic and metabolic patterns comparable to those observed in fed animals, although significantly more severe. TNF release was amplified fourfold by glucose loading, with no impact on nitrite levels. In conclusion, glucose metabolism interferes with hemodynamic, metabolic, and inflammatory responses to LPS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375321     DOI: 10.1152/jappl.1997.83.5.1566

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  17 in total

1.  Systemic pressure-flow reactivity to norepinephrine in rabbits: impact of endotoxin and fluid loading.

Authors:  A Ricard-Hibon; M R Losser; R Kong; S Beloucif; B Teisseire; D Payen
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

Review 2.  Glycemic control and organ transplantation.

Authors:  Michael R Marvin; Vicki Morton
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

3.  Maternal plasma protein profiles in response to oral 50-gram glucose load in mid-pregnancy: a pilot study.

Authors:  Daniel A Enquobahrie; Chun-Fang Qiu; Karin Hevner; Dejene Abetew; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2011-08-15

4.  Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations.

Authors:  Wen-Kui Yu; Wei-Qin Li; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.

Authors:  J R Roberson; H L Spraker; J Shelso; Y Zhou; H Inaba; M L Metzger; J E Rubnitz; R C Ribeiro; J T Sandlund; S Jeha; C-H Pui; S C Howard
Journal:  Leukemia       Date:  2008-10-16       Impact factor: 11.528

6.  A novel function of insulin in rat dermis.

Authors:  Torbjørn Nedrebø; Tine V Karlsen; Gerd S Salvesen; Rolf K Reed
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

7.  Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.

Authors:  Tal Kopel; Marie-Reine Losser; Valérie Faivre; Didier Payen
Journal:  Intensive Care Med       Date:  2008-03-26       Impact factor: 17.440

8.  Intensive insulin therapy is associated with reduced infectious complications in burn patients.

Authors:  Mark R Hemmila; Michael A Taddonio; Saman Arbabi; Paul M Maggio; Wendy L Wahl
Journal:  Surgery       Date:  2008-08-29       Impact factor: 3.982

Review 9.  The role of hyperglycemia in burned patients: evidence-based studies.

Authors:  Gabriel A Mecott; Ahmed M Al-Mousawi; Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  Shock       Date:  2010-01       Impact factor: 3.454

Review 10.  IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.

Authors:  Thomas Rimmelé; Didier Payen; Vincenzo Cantaluppi; John Marshall; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.